Inventor · disambiguated record
Michael E. Morgan
Also filed as: MORGAN MICHAEL · MORGAN MICHAEL E
13 granted patents·8 pending applications·224 citations·filing 1985–2024
92Inventor score
Top patents by PatentIndex Score
21 records- 0188US4870167AHydrophobically modified non-ionic polygalactomannan ethersHI TEK POLYMERS INC·Filed 1987·Granted Sep 26, 1989·61 cites·12 claims
- 0278US5233032AHydrophobically modified hydroxybutyl ethers of polygalactomannanSTEIN HALL & CO INC·Filed 1990·Granted Aug 3, 1993·33 cites·7 claims
- 0377US4941537AMethod for reducing the viscosity of aqueous fluidHI TEK POLYMERS INC·Filed 1989·Granted Jul 17, 1990·33 cites·24 claims
- 0473US5256651AHydrophilic-hydrophobic derivatives of polygalactomannans containing tertiary amine functionalityRHONE POULENC INC·Filed 1992·Granted Oct 26, 1993·35 cites·24 claims
- 0572US10226471B2Modified-release dosage forms of 5-HT2C agonists useful for weight managementARENA PHARM INC·Filed 2017·Granted Mar 12, 2019·1 cites·7 claims
- 0668US4677201ATitanium-glycol useful as crosslinking agents for polygalactomannansHITEK POLYMERS INC·Filed 1986·Granted Jun 30, 1987·19 cites·16 claims
- 0765US2025082607A2Methods of treating disorders with a psilocybin analogCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 0863US5179083ACoating composition containing as thickeners polygalactomannans modified with hydrophilic and hydrophobic groupsSTEIN HALL & CO INC·Filed 1990·Granted Jan 12, 1993·17 cites·13 claims
- 0960US2025213527A1Formulations of psilocybin analogs and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1059US10463676B2Modified-release dosage forms of 5-HT2C agonists useful for weight managementARENA PHARM INC·Filed 2019·Granted Nov 5, 2019·0 cites·15 claims
- 1159US2021340133A1Modulators of the gpr119 receptor and the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 1259US2024174607A1Psilocybin analogs, salts, compositions, and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 1357US10894787B2Modulators of the GPR119 receptor and the treatment of disorders related theretoJONES ROBERT M·Filed 2011·Granted Jan 19, 2021·0 cites·35 claims
- 1453US4605736ATitanium-glycol useful, as crosslinking agents, for polygalactomannansCELANESE CORP·Filed 1985·Granted Aug 12, 1986·8 cites·13 claims
- 1551US4973637APolymers made from quaternary ammonium acrylic monomersHI TEK POLYMERS INC·Filed 1990·Granted Nov 27, 1990·9 cites·11 claims
- 1647US2013315994A1Modified-release dosage forms of 5-ht2c agonists useful for weight managementSHAO ZEZHI JESSE·Filed 2011·Application pending·0 cites
- 1743US2009053306A1Pharmaceutical Compositions of a 5-HT2A Serotonin Receptor Modulator Useful for the Treatment of Disorders Related TheretoAGARWAL RAJESH K·Filed 2006·Application pending·0 cites
- 1842US2011177401A1Lithium-air cell protective membranes comprising polytetrafluoroethylene coated fiberglass clothCROWTHER OWEN·Filed 2010·Application pending·0 cites
- 1939US4918181ATertiaryaminoalkyl-hydroxyalkyl ethers of polygalactomannansKARCHER DENNIS J·Filed 1988·Granted Apr 17, 1990·6 cites·9 claims
- 2038US2011177400A1Protected lithium-air cells by oxygen-selective permeable cathode membranesCHUA DAVID·Filed 2010·Application pending·0 cites
- 2131US4918228AQuaternary ammonium acrylic monomers and alcohol soluble polymers made therefromHI TEK POLYMERS INC·Filed 1989·Granted Apr 17, 1990·2 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Michael E. Morgan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →